索拉非尼(由拜耳和Onyx Pharmac.icals共同开发并联合销售作为Nexavar)是一种激酶抑制剂药物,被批准用于治疗原发性肾癌(晚期肾细胞癌)、晚期原发性肝癌(肝细胞癌)和晚期耐放射性碘甲状腺癌.

清空选项
320-51-4

BD10345320-51-498%

¥30.0010g常备现货

220000-87-3

BD28072220000-87-397%

¥71.005g常备现货

284462-37-9

BD160159284462-37-997%

¥69.005g常备现货

98-98-6

BD1719298-98-697%

¥30.0010g常备现货

445-01-2

BD10141445-01-298%

¥61.0010g常备现货

1566-41-2

BD2276431566-41-295+%

¥2946.001g

1